U.S. Hematology Brand Lead, Navtemadlin

Role: Senior U.S. Hematology Brand Lead responsible for launching and managing Navtemadlin within the US Oncology franchise. Objectives include developing and executing comprehensive brand strategies, launch plans, and market-shaping initiatives to ensure successful adoption and sustainable growth of an oral hematology therapy. Responsibilities encompass end-to-end pre-launch planning, stakeholder engagement, market education, lifecycle management, and cross-functional leadership across Sales, Medical Affairs, Market Access, and other teams. The role also involves managing performance metrics, P&L, and external stakeholder relationships, including key opinion leaders and advocacy organizations. Qualifications: 15+ years in pharmaceutical/biotech commercial roles with proven success in hematology/oncology, including product launches, market creation, and commercialization of oral drugs. Deep understanding of treatment pathways, customer segments, and market dynamics is essential. Strong scientific acumen, leadership skills, and experience influencing senior stakeholders in complex, matrixed environments are required. Preferred: prior experience leading U.S. oncology/hematology launches involving first-in-class therapies or significant market development. Education: BA/BS required; MBA, PhD, PharmD, or MD preferred. High-value specifics include focus on hematology/oncology, oral therapies, market-shaping, and comprehensive cross-functional collaboration. This role is based in the U.S. with no specified travel requirements.